AGP Executive Report
Last update: 11 hours agoMalaria/HIV testing safety: Mozambique’s medicines regulator ANARME has suspended the sale and use of Meril Diagnostics RDTs for malaria, HIV and HIV/syphilis, plus the HIVFIND home self-test, after WHO and Mozambique’s health institute flagged major quality-management failures that could lead to wrong results. Humanitarian pressure in Cabo Delgado: OCHA says Mozambique is the only Southern Africa country still facing continuous conflict-driven humanitarian needs in Q2, with thousands displaced and basic services disrupted, as insecurity in Cabo Delgado continues to fuel aid demand. Health research investment push: Mozambique’s National Institute of Health chief Eduardo Samo Gudo urged African countries to boost funding for science and health technologies so the continent can develop its own tests and medicines instead of waiting on the global north. Mental health signal: WHO data places Mozambique among Africa’s higher suicide-rate countries, underscoring the need for stronger prevention and support services. Migration and xenophobia response (regional): South Africa’s inter-ministerial committee reaffirmed humanitarian support for affected migrants while condemning xenophobia and vigilantism, insisting repatriation is a state responsibility. Food chain risk: Reports warn unregistered pesticides entering South Africa from illicit routes, including from Mozambique, are being used in unsafe conditions and may contaminate food—especially harming children. Air cargo for medicines and perishables: Astral Aviation resumed weekly Nairobi–Guangzhou freighter service, restoring a direct cargo link that can support pharmaceuticals and other time-sensitive goods into Mozambique via onward connections.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.